Literature DB >> 27757148

Diagnosis of a Myeloproliferative Disorder in Late Pregnancy.

S Okoli1, B Wilkins2, S Robinson1, C Harrison1.   

Abstract

A 38-year-old primiparous woman presented with pre-eclampsia at 36 weeks gestation with an abnormal full blood count and leukoerythroblastic blood film. JAK2 V617F was negative and splenomegaly was noted on abdominal ultrasound. Delivery was at 37 weeks gestation by emergency caesarean section due to abnormal cardiotocography. Bone marrow aspirate and trephine confirmed a diagnosis of myelofibrosis. The case highlights a rare presentation of primary myelofibrosis in pregnancy, the difficulties in management, and the UK Obstetric Surveillance System who are collecting epidemiological data on uncommon disorders in pregnancy.

Entities:  

Keywords:  haematology; high-risk pregnancy; neoplasm

Year:  2013        PMID: 27757148      PMCID: PMC5052776          DOI: 10.1258/OM.2012.110090

Source DB:  PubMed          Journal:  Obstet Med        ISSN: 1753-495X


  5 in total

1.  Leukemias and lymphomas: time trends in the UK, 1984-93.

Authors:  R J McNally; E Roman; R A Cartwright
Journal:  Cancer Causes Control       Date:  1999-02       Impact factor: 2.506

Review 2.  The management and outcome of four pregnancies in women with idiopathic myelofibrosis.

Authors:  Sameer Tulpule; Susan Bewley; Susan E Robinson; Deepti Radia; Catherine Nelson-Piercy; Claire N Harrison
Journal:  Br J Haematol       Date:  2008-05-15       Impact factor: 6.998

Review 3.  How I treat myelofibrosis.

Authors:  Ayalew Tefferi
Journal:  Blood       Date:  2011-01-03       Impact factor: 22.113

4.  [Successful treatment of primary myelofibrosis with thrombocytosis during pregnancy with alfa-interferon].

Authors:  M Gotić; M Cvetković; T Bozanović; V Cemerikić
Journal:  Srp Arh Celok Lek       Date:  2001 Nov-Dec       Impact factor: 0.207

Review 5.  Idiopathic myelofibrosis in pregnancy: a case report and review of the literature.

Authors:  U B Taylor; A D Bardeguez; N Iglesias; P Gascon
Journal:  Am J Obstet Gynecol       Date:  1992-07       Impact factor: 8.661

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.